Works matching AU Berton, Dominique

Results: 30
    1

    Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer--The GCIG Symptom Benefit Study.

    Published in:
    Oncologist, 2017, v. 22, n. 9, p. 1117, doi. 10.1634/theoncologist.2017-0047
    By:
    • Roncolato, Felicia T.;
    • Joly, Florence;
    • O'Connell, Rachel;
    • Lanceley, Anne;
    • Hilpert, Felix;
    • Buizen, Luke;
    • Okamoto, Aikou;
    • Aotani, Eriko;
    • Pignata, Sandro;
    • Donnellan, Paul;
    • Oza, Amit;
    • Avall‐Lundqvist, Elisabeth;
    • Berek, Jonathan S.;
    • Heitz, Florian;
    • Feeney, Amanda;
    • Berton‐Rigaud, Dominique;
    • Stockler, Martin R.;
    • King, Madeleine;
    • Friedlander, Michael
    Publication type:
    Article
    2

    New systemic therapy for breast cancer.

    Published in:
    Breast Cancer (13406868), 1999, v. 6, n. 4, p. 382, doi. 10.1007/BF02966459
    By:
    • Fumoleau, Pierre;
    • Berton-Rigaud, Dominique;
    • Delecroix, Valerie;
    • Priou, Franck;
    • Bordenave, Stephanie
    Publication type:
    Article
    3
    4

    Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study.

    Published in:
    Medical Oncology, 2014, v. 31, n. 8, p. 1, doi. 10.1007/s12032-014-0076-7
    By:
    • Sehouli, Jalid;
    • Pietzner, Klaus;
    • Wimberger, Pauline;
    • Vergote, Ignace;
    • Rosenberg, Per;
    • Schneeweiss, Andreas;
    • Bokemeyer, Carsten;
    • Salat, Christoph;
    • Scambia, Giovanni;
    • Berton-Rigaud, Dominique;
    • Santoro, Armando;
    • Cervantes, Andrés;
    • Trédan, Olivier;
    • Tournigand, Christophe;
    • Colombo, Nicoletta;
    • Dudnichenko, Alexander;
    • Westermann, Anneke;
    • Friccius-Quecke, Hilke;
    • Lordick, Florian
    Publication type:
    Article
    5
    6

    Efficacy of buparlisib in treating breast cancer.

    Published in:
    Expert Opinion on Pharmacotherapy, 2017, v. 18, n. 18, p. 2007, doi. 10.1080/14656566.2017.1410139
    By:
    • Robert, Marie;
    • Frenel, Jean-Sébastien;
    • Bourbouloux, Emmanuelle;
    • Berton Rigaud, Dominique;
    • Patsouris, Anne;
    • Augereau, Paule;
    • Gourmelon, Carole;
    • Campone, Mario
    Publication type:
    Article
    7
    8

    "Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".

    Published in:
    2021
    By:
    • Gernier, François;
    • Ahmed-Lecheheb, Djihane;
    • Pautier, Patricia;
    • Floquet, Anne;
    • Nadeau, Cédric;
    • Frank, Sophie;
    • Alexandre, Jérôme;
    • Selle, Frédéric;
    • Berton-Rigaud, Dominique;
    • Kalbacher, Elsa;
    • Orfeuvre, Hubert;
    • Lortholary, Alain;
    • Augereau, Paule;
    • Labombarda, Fabien;
    • Perrier, Lionel;
    • Grellard, Jean-Michel;
    • Licaj, Idlir;
    • Clarisse, Bénédicte;
    • Savoye, Aude-Marie;
    • Bourien, Héloise
    Publication type:
    journal article
    9

    Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 6, p. 1998, doi. 10.1007/s00259-020-05092-3
    By:
    • Aide, Nicolas;
    • Fauchille, Pauline;
    • Coquan, Elodie;
    • Ferron, Gwenael;
    • Combe, Pierre;
    • Meunier, Jérome;
    • Alexandre, Jerôme;
    • Berton, Dominique;
    • Leary, Alexandra;
    • De Rauglaudre, Gaétan;
    • Bonichon, Nathalie;
    • Pujade Lauraine, Eric;
    • Joly, Florence
    Publication type:
    Article
    10

    Population pharmacokinetics and exposure–response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY.

    Published in:
    British Journal of Clinical Pharmacology, 2025, v. 91, n. 3, p. 841, doi. 10.1111/bcp.16325
    By:
    • Kuchimanchi, Mita;
    • Jørgensen, Trine Lembrecht;
    • Hanze, Eva;
    • André, Thierry;
    • Jain, Angela;
    • Berton, Dominique;
    • Alskär, Oskar;
    • Zub, Oleksandr;
    • Oaknin, Ana;
    • Shahin, Mark S.;
    • Koliadi, Anthoula;
    • Pothuri, Bhavana;
    • Krivak, Tom;
    • Pishchyk, Mikalai;
    • Segev, Yakir;
    • Backes, Floor J.;
    • Gennigens, Christine;
    • Bouberhan, Sara;
    • Zajic, Stefan;
    • Melhem, Murad
    Publication type:
    Article
    11
    12
    13

    Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients.

    Published in:
    Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.711813
    By:
    • Berton, Dominique;
    • Floquet, Anne;
    • Lescaut, Willy;
    • Baron, Gabriel;
    • Kaminsky, Marie-Christine;
    • Toussaint, Philippe;
    • Largillier, Rémy;
    • Savoye, Aude-Marie;
    • Alexandre, Jérôme;
    • Delbaldo, Catherine;
    • Malaurie, Emmanuelle;
    • Barletta, Hugues;
    • Bosacki, Claire;
    • Garnier-Tixidre, Claire;
    • Follana, Philippe;
    • Laharie-Mineur, Hortense;
    • Briac Levache, Charles;
    • Valenza, Bruno;
    • Dechartres, Agnès;
    • Mollon-Grange, Delphine
    Publication type:
    Article
    14

    Recommandations de prise en charge des inhibiteurs de PARP en pratique infirmière - Retour sur les résultats d'un consensus national Delphi.

    Published in:
    Bulletin Infirmier du Cancer, 2023, v. 23, n. 1, p. 45, doi. 10.1684/bic.2023.233
    By:
    • Dielenseger, Pascale;
    • Matta, Carla;
    • Angelergues, Antoine;
    • Augereau, Paule;
    • Berton, Dominique;
    • Fabbro, Michel;
    • Falandry, Claire;
    • Follana, Philippe;
    • Gladieff, Laurence;
    • Joly, Florence;
    • Kurtz, Jean-Emmanuel;
    • Mouret-Reynier, Marie-Ange;
    • Schmitt, Antonin;
    • Scotté, Florian;
    • Marjollet, Coralie;
    • Selle, Frédéric
    Publication type:
    Article
    15

    Impact of paclitaxel on pazopanib pharmacokinetics in patients with ovarian cancers from phase II trial TAPAZ.

    Published in:
    European Journal of Gynaecological Oncology, 2025, v. 46, n. 5, p. 24, doi. 10.22514/ejgo.2025.062
    By:
    • Carrot, Aurore;
    • You, Benoit;
    • Joly-Lobbedez, Florence;
    • Fabbro, Michel;
    • Berton, Dominique;
    • Lequesne, Justine;
    • Floquet, Anne;
    • Cancel, Mathilde;
    • Bourgeois, Hugues;
    • Lefevre, Leïla Bengrine;
    • Pommeret, Fanny;
    • Lortholary, Alain;
    • Spaeth, Dominique;
    • Martin-Babau, Jérôme;
    • Abdeddaim, Cyril;
    • Kaminsky-Forrett, Marie-Christine;
    • Petran, Daniela;
    • Gross, Magali Provansal;
    • Guitton, Jérôme;
    • Payen, Léa
    Publication type:
    Article
    16

    Trastuzumab deruxtecan in previously treated HER2‐positive metastatic or unresectable breast cancer: Real‐life data from the temporary use authorization program in France.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 9, p. 1, doi. 10.1002/cam4.7168
    By:
    • Petit, Thierry;
    • Hajjaji, Nawale;
    • Antoine, Eric‐Charles;
    • Benderra, Marc‐Antoine;
    • Gozy, Michel;
    • Foa, Cyril;
    • Mouysset, Jean‐Loup;
    • Grenier, Julien;
    • Mousseau, Mireille;
    • Mailliez, Audrey;
    • Saghatchian, Mahasti;
    • Lachaier, Emma;
    • Desmoulins, Isabelle;
    • Hennequin, Audrey;
    • Maes, Patricia;
    • Loirat, Delphine;
    • Ricci, Francesco;
    • Diéras, Véronique;
    • Berton, Dominique;
    • Tiong, Florence Lai
    Publication type:
    Article
    17

    Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.

    Published in:
    PLoS ONE, 2018, v. 13, n. 10, p. 1, doi. 10.1371/journal.pone.0204973
    By:
    • Cottu, Paul H.;
    • Bonneterre, Jacques;
    • Varga, Andrea;
    • Campone, Mario;
    • Leary, Alexandra;
    • Floquet, Anne;
    • Berton-Rigaud, Dominique;
    • Sablin, Marie-Paule;
    • Lesoin, Anne;
    • Rezai, Keyvan;
    • Lokiec, François M.;
    • Lhomme, Catherine;
    • Bosq, Jacques;
    • Bexon, Alice S.;
    • Gilles, Erard M.;
    • Proniuk, Stefan;
    • Dieras, Veronique;
    • Jackson, David M.;
    • Zukiwski, Alexander;
    • Italiano, Antoine
    Publication type:
    Article
    18

    The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research.

    Published in:
    Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-02073-0
    By:
    • Moniot, Aurélie;
    • Schneider, Christophe;
    • Chardin, Laure;
    • Yaniz-Galende, Elisa;
    • Genestie, Catherine;
    • Etiennot, Marion;
    • Henry, Aubéri;
    • Drelon, Coralie;
    • Le Formal, Audrey;
    • Langlois, Benoit;
    • Venat, Laurence;
    • Louvet, Christophe;
    • Favier, Laure;
    • Lortholary, Alain;
    • Berton-Rigaud, Dominique;
    • Dohollou, Nadine;
    • Desauw, Christophe;
    • Fabbro, Michel;
    • Malaurie, Emmanuelle;
    • Dubot, Coraline
    Publication type:
    Article
    19

    Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network.

    Published in:
    Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092345
    By:
    • Bonsang-Kitzis, Hélène;
    • Panchbhaya, Nabilah;
    • Bats, Anne-Sophie;
    • Pujade-Lauraine, Eric;
    • Pautier, Patricia;
    • Ngô, Charlotte;
    • Le Frère-Belda, Marie-Aude;
    • Kalbacher, Elsa;
    • Floquet, Anne;
    • Berton-Rigaud, Dominique;
    • Lefeuvre-Plesse, Claudia;
    • Fabbro, Michel;
    • Ray-Coquard, Isabelle;
    • Lécuru, Fabrice
    Publication type:
    Article
    20

    Therapeutic Challenges in Patients with Gynecologic Carcinosarcomas: Analysis of a Multicenter National Cohort Study from the French Prospective TMRG Network.

    Published in:
    Cancers, 2022, v. 14, n. 2, p. 354, doi. 10.3390/cancers14020354
    By:
    • Romeo, Clémence;
    • Le Saux, Olivia;
    • Jacobs, Margaux;
    • Joly, Florence;
    • Ferron, Gwenael;
    • Favier, Laure;
    • Fumet, Jean-David;
    • Isambert, Nicolas;
    • Colombo, Pierre-Emmanuel;
    • Sabatier, Renaud;
    • Bastide, Ludovic;
    • Charreton, Amandine;
    • Devouassoux-Shisheboran, Mojgan;
    • Gertych, Witold;
    • Dubot, Coraline;
    • Bello Roufai, Diana;
    • Bataillon, Guillaume;
    • Berton, Dominique;
    • Kalbacher, Elsa;
    • Pautier, Patricia
    Publication type:
    Article
    21
    22

    Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancer.

    Published in:
    Expert Opinion on Drug Metabolism & Toxicology, 2019, v. 15, n. 2, p. 85, doi. 10.1080/17425255.2019.1559816
    By:
    • Robert, Marie;
    • Frenel, Jean-Sébastien;
    • Bourbouloux, Emmanuelle;
    • Berton Rigaud, Dominique;
    • Patsouris, Anne;
    • Augereau, Paule;
    • Gourmelon, Carole;
    • Campone, Mario
    Publication type:
    Article
    23

    Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.

    Published in:
    2018
    By:
    • King, Madeleine T.;
    • Stockler, Martin R.;
    • O’Connell, Rachel L.;
    • Buizen, Luke;
    • Joly, Florence;
    • Lanceley, Anne;
    • Hilpert, Felix;
    • Okamoto, Aikou;
    • Aotani, Eriko;
    • Bryce, Jane;
    • Donnellan, Paul;
    • Oza, Amit;
    • Avall-Lundqvist, Elisabeth;
    • Berek, Jonathan S.;
    • Sehouli, Jalid;
    • Feeney, Amanda;
    • Berton-Rigaud, Dominique;
    • Costa, Daniel S. J.;
    • Friedlander, Michael L.;
    • for the GCIG Symptom Benefit group
    Publication type:
    journal article
    24
    25
    26

    NY-ESO-1-Specific Circulating CD4<sup>+</sup> T Cells in Ovarian Cancer Patients Are Prevalently T<sub>H</sub>1 Type Cells Undetectable in the CD25<sup>+</sup> FOXP3<sup>+</sup> Treg Compartment.

    Published in:
    PLoS ONE, 2011, v. 6, n. 7, p. 1, doi. 10.1371/journal.pone.0022845
    By:
    • Redjimi, Nassima;
    • Duperrier-Amouriaux, Karine;
    • Raimbaud, Isabelle;
    • Luescher, Immanuel;
    • Dojcinovic, Danijel;
    • Classe, Jean-Marc;
    • Berton-Rigaud, Dominique;
    • Frene, Jean-Sébastien;
    • Bourboulox, Emmanuelle;
    • Valmori, Danila;
    • Ayyoub, Maha
    Publication type:
    Article
    27

    Pertuzumab for the treatment of breast cancer.

    Published in:
    2020
    By:
    • Robert, Marie;
    • Frenel, Jean-Sébastien;
    • Bourbouloux, Emmanuelle;
    • Berton Rigaud, Dominique;
    • Patsouris, Anne;
    • Augereau, Paule;
    • Gourmelon, Carole;
    • Campone, Mario
    Publication type:
    journal article
    28

    Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.

    Published in:
    JAMA Network Open, 2023, v. 6, n. 11, p. e2341165, doi. 10.1001/jamanetworkopen.2023.41165
    By:
    • André, Thierry;
    • Berton, Dominique;
    • Curigliano, Giuseppe;
    • Sabatier, Renaud;
    • Tinker, Anna V.;
    • Oaknin, Ana;
    • Ellard, Susan;
    • de Braud, Filippo;
    • Arkenau, Hendrik-Tobias;
    • Trigo, José;
    • Gravina, Adriano;
    • Kristeleit, Rebecca;
    • Moreno, Victor;
    • Abdeddaim, Cyril;
    • Vano, Yann-Alexandre;
    • Samouëlian, Vanessa;
    • Miller, Rowan;
    • Boni, Valentina;
    • Torres, Antonio Antón;
    • Gilbert, Lucy
    Publication type:
    Article
    29

    Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node‐positive, early‐stage, invasive breast carcinoma undergoing breast‐conserving surgery: Results of the French Adjuvant Study Group.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 2, p. 240, doi. 10.1002/cncr.21161
    By:
    • Mohamed Benchalal;
    • Elisabeth Le Prisé;
    • Brigitte de Lafontan;
    • Dominique Berton‐Rigaud;
    • Yazid Belkacemi;
    • Pascale Romestaing;
    • Karine Peignaux;
    • Adel Courdi;
    • Alain Monnier;
    • Philippe Montcuquet;
    • Marie‐Josèphe Goudier;
    • Christian Marchal;
    • Philippe Chollet;
    • Sophie Abadie‐Lacourtoisie;
    • Jean Datchary;
    • Corinne Veyret;
    • Pierre Kerbrat
    Publication type:
    Article
    30

    Early Death in Advanced Ovarian Cancer in Older Adults.

    Published in:
    Journal of the American Geriatrics Society, 2014, v. 62, n. 5, p. 976, doi. 10.1111/jgs.12808
    By:
    • Lefur, Eloise;
    • Berton‐Rigaud, Dominique;
    • Boureau, Anne S.;
    • Chapelet, Guillaume;
    • Berrut, Gilles;
    • Decker, Laure
    Publication type:
    Article